Curriculum vitae matthew ryan weir, M. D



Download 0.51 Mb.
Page5/7
Date conversion04.02.2017
Size0.51 Mb.
1   2   3   4   5   6   7

BOOKS





    1. Weir, MR, editor. Medical Management of Kidney Transplantation. Lippincott Williams & Wilkins Philadelphia, PA, 2005.

    2. Weir, MR, editor. Hypertension. American College of Physicians. Philadelphia, PA, 2005.

    3. Weir MR, Sica, DA, editors. Contemporary Diagnosis and Management of The Hypertensive Patient. Handbooks in Health Care. Newtown, PA, 2009.

    4. Weir MR. Evidence-based Management of Hypertension. Tfm Pub Ltd, Castle Hill Barns, Harley, Nr Shrewsbury, UK, 2010.


ABSTRACTS

1. Weir MR, Thornton GF. Extrapulmonary tuberculosis: The experience of a community hospital. American Federation for Clinical Research. October, 1981 (Presented). Clinical Research, 1981; 29: 380A.

2. Kirkman RL, Strom TB, Weir MR, Tilney NL. Late mortality and morbidity in recipients of long-term renal allografts. Proceedings of the American Society of Transplant Surgeons. May, 1982 (Presented). American Society of Transplant Surgeons. Abstract Book, 1982;8.

3. Kirkman RL, Strom TB, Weir MR, Tilney NL. The natural history of long-term renal transplantation. Proceedings of the International Congress of the Transplantation Society. August, 1982 (Presented). International Congress of the Transplantation Society Abstract Book, 1982; 8.

4. Weir MR, Kirkman RL, Strom TB, Tilney NL. Rehabilitation in recipients of long-term renal allografts. Proceedings of the American Society of Nephrology. November, 1982 (Presented). Kidney International, 1983; 23: 297.

5. Weir MR, Cohen DJ, Carpenter CB. Analysis of the alloimmune response of pre-sensitized animals: Compartmentalization of primed clones. American Federation for Clinical Research. May, 1983. Clinical Research, 1983; 31: 356A.

6. Weir MR, Cohen DJ, Carpenter CB. Compartmentalization of the immune response to repetitive stimulation with alloantigen. American Federation for Clinical Research. October, 1983 (Presented). Clinical Research, 1983; 31:690A.

7. Weir MR, Cohen DJ, Carpenter CB. Allograft transplantation subsequent to active and passive enhancement leads to compartmentalization of the immune response. American Federation for Clinical Research. October, 1983 (Presented). Clinical Research, 1983; 31:690A.

8. Weir MR, Kirkman RL, Strom TB, Tilney NL. Chronic liver disease in recipients of long-term renal allografts: Analysis of morbidity and mortality. Proceedings of the American Society of Nephrology. December, 1983 (Presented). Kidney International, 1984; 25:352.

9. Weir MR, Cohen DJ, Carpenter CB. Dissimilar immune responses to varied presentation of identical alloantigens. Proceedings of the International Congress of Nephrology Abstract Book, 1984; 9:267A.

10. Weir MR, Kirkman RL, Strom TB. Long-term effects of hepatitis B virus in renal transplant recipients: Analysis of morbidity and mortality. Proceedings of the International Congress of the Transplantation Society. August, 1984 (Presented). International Congress of the Transplantation Society Abstract Book, 1984; 10:312.

11. Hoopes J, Ryan P, Muncie H, McDermott D, Weir MR, Tenney J. Can serum creatinine be used to estimate accurately measured creatinine clearance in the aged? American Gerontological Society. November, 1984. Abstract Book of American Gerontological Society, 1984.

12. Posner JN, Weir MR, Hall-Craggs M, Shen YS, Alongi SV, Dagher FJ. Prognostic value of peripheral blood and renal biopsy eosinophilia in acute renal allograft rejection. Proceedings of the American Society of Nephrology. December, 1984. Kidney International, 1985, 27:346.

13. Josselson J, Weir MR, Sadler JH. Morbidity and mortality in a twice-weekly maintenance hemodialysis program. Proceedings of the American Society of Nephrology. December, 1984. Kidney International, 1985; 27:164.

14. Weir MR, Josselson J, Sadler JH Bi-weekly vs. thrice-weekly hemodialysis: Five year analysis of morbidity and mortality. Proceedings of the American Society of Nephrology. December, 1984 (Presented). Kidney International, 1985; 27:175.

15. Shen YS, Weir MR, Litkowski LJ, Anthony RL, Welik RA Kosenko, A, Light PD, Dagher FJ, Sadler JH. Diagnosis of transplant rejection and cyclosporine toxicity by measurement of human renal proximal tubular epithelial antigen in the serum. American Society of Transplant Physicians. May, 1985 (Presented). American Society of Transplant Physicians Abstract Book, 1985; 4:39.

16. Kosenko A, Shen SY, Weir MR, Revie D, Ordonez J, Dagher FJ, Sadler JH, Chreitien P. Re-evaluation of T-cell subset monitoring in renal allograft recipients treated with cyclosporine. May, 1985 (Presented). American Society of Transplant Physicians Abstract Book, 1985; 4:10.

17. Weir MR, Zemel S, Shen SY, Welik R, Peppler R, McRoy C, Sadler JH, Leavitt R. Acute effects of hemodialysis on lymphocyte subpopulations and mitogenic response to PHA. American Federation of Clinical Research. September, 1985 (Presented) Clinical Research, 1985; 33:770A.

18. Zemel S, Weir MR, Welik R, Shen SY, Peppler R, McRoy C, Sadler JH. Effects of age and uremia on lymphocyte mitogenic response in end-stage renal disease patients. American Federation of Clinical Research. September, 1985 (Presented) Clinical Research, 1985; 33:770A.

19. Welik R, Urbaitis B, Weir MR, Shen SY, Zemel S, McRoy C, Peppler R, Sadler JH. Intracellular ATP levels in the lymphocytes of dialysis patients as a possible explanation for decreased mitogenic response. American Federation of Clinical Research. September, 1985 (Presented). Clinical Research, 1985; 33:763A.

20. Forrest A, Weir MR, Plaisance K, Drusano G, Caldwell J, Bustamante C, Leslie J, Standford H. Effects of renal dysfunction on pharmaco-kinetics of oral ciprofloxacin. Abstract 1002, Program and Abstracts of the 25th Interscience Conference for Antimicrobial Agents and Chemotherapy. (29 Sept.-2 Oct., 1985). (Presented).

21. Zemel S, Shen SY, Lesko L, Weir MR, Kosenko A, Dagher FJ, Bentley F. Optimal cyclosporine through whole blood level by high pressure liquid chromatography in renal transplants treated with a single daily dose. National Kidney Foundation. December, 1985. American Journal of Kidney Disease, 1985; VI:A25.

22. Welik R, Urbaitis B, Weir MR, Shen SY, Zemel S, McRoy C, Peppler R, Sadler JH. Lymphocyte ATP and mitogenic response in normal and hemodialysis patients. American Society of Nephrology. December, 1985. Kidney International, 1986; 29:327.

23. Weir MR, Josselson J, Hebel R, Yen M, Sadler JH. Mortality risk on maintenance hemodialysis: A five year retrospective analysis. American Society of Nephrology, December, 1985. Kidney International 1986; 29:228.

24. Shen SY, Weir MR, Bentley R, Dagher FJ. Conversion of cyclosporine therapy to azathioprine in renal transplants. American Society of Nephrology. December, 1985. Kidney International 1986; 29:435.

25. Josselson J, Kyser B, Weir MR, Sadler JH. Chronic hepatitis B antigen does not increase morbidity or mortality in hemodialysis patients. American Society of Nephrology. December, 1985. Kidney International 1986; 29:216.

26 Shen SY, Welik R, Zemel S, Weir MR, Sadler JH. Lymphocytic function and status of hepatitis B antigen and antibody in hemodialysis patients. National Kidney Foundation. December, 1985. American Journal of Kidney Diseases 1985; VI:A19.

27. Weir MR, Zemel S, Shen SY, Welik R, Peppler R, McRoy C, Sadler JH, Leavitt R. Acute effects of hemodialysis on lymphocyte subpopulations and mitogenic response to PHA. Joint Session National Kidney Foundation/American Society of Nephrology. December 1985 (Presented). American Journal of Kidney Diseases, 1985; VI:A23.

28. Zemel S, Weir MR, Welik R, Shen SY, Peppler R, McRoy C, Sadler JH, Leavitt R. Effects of age and end-stage renal disease on lymphocyte mitogenic response in hemodialysis patients. American Society of Nephrology. December, 1985 (Presented). Kidney International, 1986; 29:229.

29. Weir MR, Irwin BC, Gemenans G, Maters A, Shen SY, Charache P, Williams GM. High morbidity and mortality associated with the transplantation of a cytomegalovirus-positive kidney into a cytomegalovirus-negative recipient. American Society of Transplant Physicians. May, 1986 (Presented). American Society of Transplant Physicians Abstract Book, 1986; 5:1.

30. Shen SY, Zemel S, Weir MR, Dagher FJ, Bentley FR, Sadler JH. Renal allograft biopsy and conversion of cyclosporine to azathioprine. American Society of Transplant Physicians. May, 1986 (Presented). American Society of Transplant Physicians Abstract Book, 1986; 5:27.

31. Shen, SY, Zemel, S, Weir, MR, Dagher, FJ, Bentley, FR. Renal allograft biopsy at the time of cyclosporine conversion can detect occult rejection and preserve graft function. XI International Congress of the Transplantation Society, August, 1986 (Presented). XI International Congress of the Transplantation Society Abstract Book, 1986, P 33.11.

32. Irwin BC, Weir MR, Maters AW Genemans G, Shen SY., Charache P, Williams GM. Morbid outcome of cytomegalovirus-negative transplant recipients receiving cytomegalovirus-positive kidneys. XI International Congress of the Transplantation Society, August, 1986, (Presented). XI International Congress of the Transplantation Society Abstract Book, 1986, P 37.5.

33. Weir MR, Shen SY, Dagher FJ, Bentley FR, Sadler JH. A short term analysis of the effect of cyclosporine and source leukocyte transfusions on the cytotoxic antibody production of highly sensitized prospective renal transplant recipients. XI International Congress of the Transplantation Society, August, 1986 (Presented). XI International Congress of the Transplantation Society Abstract Book, 1986, P 11.1.

34. Bentley FR, Shen SY, Weir MR, Revie D, Dagher FJ, Chretien P, Sadler JH. Differentiation of acute rejection from acute cyclosporine nephrotoxicity in renal allograft recipients by peripheral blood T-cell subsets counts. International Congress of the Transplantation Society, August, 1986 (Presented). XI International Congress of the Transplantation Society Abstract Book, 1986, P 32.28.

35. Zemel SM, Shen SY, Weir MR, Dagher FJ, Bentley FR. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine. XI International Congress of the Transplantation Society, August 1986 (Presented). XI International Congress of the Transplantation Society Abstract Book, 1986, P 33.10.

36. Plaisance K, Drusano G, Forrest A, Weir MR, Standiford H. The effect of renal function on the bioavailability of ciprofloxacin. 26th Interscience Conference for Antimicrobial Agents and Chemotherapy, September, 1986 (Presented).

37. Drusano GL, Weir MR, Forrest A, Plaisance K, Emm T, Standiford H. The pharmacokinetics of intravenous ciprofloxacin in patients with varying degrees of renal dysfunction. 26th Interscience Conference for Antimicrobial Agents and Chemotherapy, September, 1986 (Presented).

38. Weir MR, Peppler R, Handwerger BS. Inhibition of human peripheral blood mononuclear cell function by verapamil. American Society of Nephrology, December, 1986 (Presented). Kidney International 1987;31:471.

39. Josselson J, Weir MR, Hebel JR, Gardner J, Evans D, Sadler JH. Intravenous drug abuse: A marker for reduced success in patients with end-stage renal disease on hemodialysis. American Society of Nephrology, 1986. Kidney International 1987; 32:234.

40. Weir MR, Josselson J, Hebel JR, Sadler JH, Saunders E. End-stage renal disease secondary to hypertension: 5 year analysis of morbidity and mortality. Second International Interdisciplinary Conference on Hypertension in Blacks, Atlanta, Ga., March, 1987;2:45 (Presented).

41. Weir MR, Peppler R, Gomolka D, Handwerger BS. Inhibition of activation and function of human peripheral blood mononuclear cells by verapamil. International Society of Nephrology, London, U.K., July, 1987 (Presented). International Society of Nephrology Abstract Book 1987; 10:605.

42. Weir MR, Peppler R, Gomolka D, Handwerger BS. Additive effects of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells. American Society of Transplant Physicians, Chicago, Il., May, 1987 (Presented). American Society of Transplant Physicians Abstract Book 1987; 6:24.

43. Weir MR, Henry ML, Blackmore M, Smith J, First MR, Irwin B, Shen SY, Genemans G, Shield CF, Kittur D, Williams GM, Corry RJ. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor specific transfusion and living-related donor transplantation. A multi-center evaluation. American Society of Transplant Physicians, Chicago, Il, May, 1987 (Presented). American Society of Transplant Physicians Abstract Book 1987; 6:61.

44. Weir MR, Peppler R, Gomolka D, Handwerger BS. Additive inhibition of human peripheral blood mononuclear function by verapamil and cyclosporine. Second International Conference on Cyclosporine, Washington, D.C., November, 1987. (Presented). Second International Congress on Cyclosporine Abstract Book 1987; 2:284.

45. Weir MR, Peppler R, Gomolka D, Handwerger BS. Inhibitory effect of verapamil on the activation and function of human peripheral blood mononuclear cells is additive with cyclosporine and may occur through calcium independent mechanisms, American Society of Nephrology, Washington, D.C., December 1987 (Presented). Kidney International 1988, 33:455.

46. Weir MR, Klassen DK, Hoover N, Douglas F. Effects of a thromboxane synthetase inhibitor (CGS 13080) on blood pressure, renal hemodynamics and prostaglandin (PG) production in hypertensive humans. 3rd Annual Meeting, American Society of Hypertension, 1988. (Presented) American Journal of Hypertension 1988; 1:69A.

47. Weir MR, Vlachkis ND, DeQuattro V, et al. Efficacy and safety of Nilvadipine in hypertension. 3rd Annual Meeting, American Society of Hypertension, 1988. (Presented) American Journal of Hypertension. 1988; 1:17A.

48. Shen SY, Wood C, Papadimitrou JC, Amin A, Weir MR, Coughlin T. Dermal angiopathy in renal transplants with cyclosporine nephrotoxicity. 7th Annual Meeting, American Society of Transplant Physicians, 1988 and XII International Congress of the Transplantation Society, 1988. (Presented) American Society of Transplant Physicians Abstract Book 1988; 7:83.

49. Shen SY, Weir MR, Coughlin T. Conversion of cyclosporine to azathioprine in renal transplants 7th Annual Meeting, American Society of Transplant Physicians, 1988. (Presented) American Society of Transplant Physicians Abstract Book 1988; 7:107.

50. Weir MR, Klassen DK, Shen SY, Sullivan D, Buddemeyer EU, Handwerger BS, Kowarski AA. The acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans. 7th Annual Meeting, American Society of Transplant Physicians, 1988. (Presented) American Society of Transplant Physicians Abstract Book 1988; 7:47.

51. Weir MR, Klassen DK, Shen SY. Effect of verapamil on renal hemodynamics in normotensives. American Heart Association 1988 (Presented) Circulation 1988; 78:1450.

52. Weir MR, Peppler R, Gomolka D, Handwerger BS. Additive inhibitory effect of cyclosporine and verapamil may occur through different mechanisms which may be dependent or independent of the slow calcium channel. (Presented) XII International Congress of the Transplantation Society, 1988; 12:159.

53. Weir MR, Gomolka D, Peppler R, Handwerger BS. Mechanisms of additive inhibition of immunologic responses by cyclosporine and verapamil. 21st meeting of the American Society of Nephrology. (Presented). Kidney International 1989; 35:366.



  1. Li XW, Weir MR. Tripterygium Wilfordii inhibits afferent immunologic responses of human peripheral blood

mononuclear cells. 21st meeting of the American Society of Nephrology. Kidney International 1989; 35:353.

55. Weir MR, Saunders E, Kong BW. A comparison of the efficacy of atenolol, captopril and verapamil SR in hypertensive blacks. 4th Annual Meeting of the American Society of Hypertension. (Presented) 1989; 2:21A.

56. Weir MR, Burris JF, Oparil S, Weber M, Cady WJ. A multifactorial evaluation of the antihypertensive efficacy of the combination of diltiazem and hydrochlorothiazide. 4th Annual Meeting of the American Society of Hypertension. (Presented) Am J Hypertens 1989; 2:21A.

57. Weir MR, Gomolka D, Peppler R, Handwerger BS. Mechanisms of additive inhibition of immunological responses by verapamil and cyclosporine. 8th Annual Meeting of the American Society of Transplant Physicians. (Presented) American Society of Transplant Physicians Book 1989; 8:67.

58. Weir MR, Klassen DK, Shen SY, Sullivan D, Buddemeyer EU, Handwerger BS. The acute effects of intravenous cremophor EL on blood pressure, renal hemodynamics and urine prostaglandin production of healthy humans. 8th Annual Meeting of the American Society of Transplant Physicians. (Presented) American Society of Transplant Physicians Book 1989; 8:110.

59. Shen SY, Amin A, Behrens MT, Weir MR, Klassen DK, Coughlin TR. How beneficial is OKT-3 as an immunosuppressive induction agent? 8th Annual Meeting of the American Society of Transplant Physicians. (Presented) American Society of Transplant Physicians Book 1989; 8:88.

60. Weir MR, Klassen DK, Hall PS, Schubert C. Misoprostol minimizes Indomethacin-induced renal dysfunction in healthy women: a preliminary report. 22nd Annual Meeting of the American Society of Nephrology, 1989. Kidney Int 1990; 37:497.

61. Li XW, Weir MR Gomolka D, Peppler R, Moran M, O'Bryan-Tear G. Immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor. 22nd Annual Meeting of the American Society of Nephrology, 1989. Kidney Int 1990; 37:421.

62. Klassen DK, Weir MR, Buddemeyer EU. Simultaneous measurements of glomerular filtration rate by radioisotopic methods and creatinine clearance. 22nd Annual Meeting of the American Society of Nephrology, 1989. Kidney Int 1990; 37:277.

63. Li XW, Weir MR, Shen SY. Tripterygium Wilfordii, a chinese herbal medicine with potent immunosuppressive properties. 19th Annual meeting of the National Kidney Foundation, 1989 Am J Kid Dis 1990; 15 (4):A13 (Presented).

64. Weir MR, Josselson J, Ekelund L, Korc M, Pool J, Stein G. Favorable effects of nicardipine on the quality of life during hypertension treatment. 5th Annual Meeting of the American Society of Hypertension. Am J Hypertens 1990; 3:105. (Presented).

65. Weir MR, Gomolka MA, Peppler R. Verapamil has immunosuppressive properties unrelated to its ability to block slow calcium channel. 9th Annual Meeting of the American Society of Transplant Physicians. American Society of Transplant Physicians Book 1990; 9:166. (Presented).

66. Weir MR, Peppler R, Gomolka D, Xue-Wang L, Moran M, O'Bryan-Ter G. Immunosuppressive properties of nisoprost and SC45662 (5-Lipoxygenase Inhibitor). 9th Annual Meeting of the American Society of Transplant Physicians. American Society of Transplant Physicians Book 1990; 9:44. (Presented).

67. Muluk SC, Via SS, Weir MR, Clerici M, Shearer GM. In vitro MHC self-restricted CD4+ T helper cell response to alloantigen correlates with clinical graft status in immunosuppressed kidney transplant recipients. 9th Annual Meeting of the American Society of Transplant Physicians. American Society of Transplant Physicians Book 1990; 9:167. (Presented).

68. Klassen DK, Weir MR, Evans DP, Coughlin TR. Oliguria associated with OKT3 induction immunosuppression in cadaveric renal allografts. 9th Annual Meeting of the American Society of Transplant Physicians. American Society of Transplant Physicians Book 1990; 9:194. (Presented).

69. Muluk SC, Via CS, Weir MR, Clerci M, Shearer G. In vitro MHC self-restricted CDA+T helper cell response to alloantigen correlates with clinical graft status in immunosuppressed kidney transplant recipients XIII International Congress of the Transplantation Society Abstract Book 1990; 78. (Presented).

70. Gomolka D, Weir MR, Peppler R. Immunosuppressive properties of enisoprost and SC45662. XIII International Congress of the Transplantation Society Abstract Book 1990; 290. (Presented).

71. Gomolka D, Weir MR, Peppler R. The antiproliferative effect of verapamil on human peripheral blood lymphocytes is independent of calcium channel inhibitors. J Am Soc Nephrol 1990; 1:748. (Presented).

72. Weir MR, Klassen, DK, Burdick JF, Geiser R, Als A. Suppression of urinary thromboxane does not improve renal function in cyclosporine-treated renal transplant recipients. J Am Soc Nephrol 1990;1:774. (Presented).

73. Gottlieb SS, Robinson S, Weir MR, Fisher M, Kritchen C. Determinants of the renal response to ACE inhibitors in congestive heart failure. Circulation 1990; 82:III-386. (Presented).

74. Weir MR, Peppler R, Gomolka D, Handwerger BS. The antiproliferative effect of verapamil on human peripheral blood mononuclear cells is independent of calcium channel inhibition. Am Soc Transplant Phys Abstract Book 1991; 10:1076. (Presented)

75. Peppler, Weir MR, Gomolka D, Handwerger BS. The antiproliferative effect of verapamil on lymphocytes is related to inhibition of cellular potassium efflux with secondary inhibition of transmembrane calcium flux. J Am Soc Neph 1991; 2:785 (Presented).

76. Weir MR, Bhandaru S, Bakris GL. Inhibition of insulin-mediated mesangial cell proliferation is unrelated to blockade of the voltage-gated slow calcium channel. J Am Soc Neph 1991; 2:470.

77. Weir MR, Behrens MT, Peppler R, Zemel MB. Effects of salt and isradipine on platelet Ca++ in salt sensitive and insensitive hypertensive patients. American Society of Hypertension 1992; 5:66A (Presented).

78. Weir MR, Behrens MT, Zemel MB. Renal hemodynamic and antihypertensive effects on isradipine of salt-insensitive hypertensive patients on high and low sodium diets. NIDDK conference: Kidney Disease and Hypertension in Blacks. Abstract Book 1991; 12 (Presented).

79. Weir MR, Behrens MT, Hall PS, Zemel MB. Differing hemodynamic responses to sodium intake in black and white hypertensives. Clinical Research 1992; 40:286A (Presented).

80. Gottlieb SS, Weir MR, Robinson SW, Krichten CM, Fisher ML. Does the effect of ACE inhibition on renal function depend on dosing frequency? Clinical Research 1992; 40:233A (Presented).

81. Weir MR, Peppler R, Gomolka D, Handwerger BS. Mechanisms responsible for inhibition of lymphocyte activation by agents which block membrane calcium or potassium channels. Am Soc Transplant Physicians Abstract Book 1992; 11:199 (Presented).

82. Behrens MT, Weir MR, Hall PS, Zemel MB. Higher sodium intake in salt resistant black and white hypertensives does not lead to alterations in renal hemodynamics. J Am Soc Neph 1992; 3:558.

83. Schulick RD, Weir MR, Cohen DJ, Miller MW, Shearer GM. Time-dependents changes of in vitro CD4+ T helper function in renal transplant patients. 1992 National Kidney Foundation Annual Meeting (Presented).

84. Schoenberger JA, Weir MR, Wolfsen PM, Fishman WH, Cargo PH, Lefkowitz MP, Targum SL, Weber MA. A placebo controlled study of verapamil in the treatment of hypertension in the elderly. Am J Hypertens 1993; 6:123A (Presented)

85. Weir MR, Gomolka D, Handwerger BS. Inhibition of lymphocyte activation by drugs that block calcium and potassium channels. Further insight into mechanisms of action. American Society of Transplant Physicians Abstract Book 1993; 12:311. (Presented).

86. Keay S, Baldwin B, Weir MR. Inhibition of CMV replication in vitro by the immunosuppressive agents Cyclosporine A, FK-506, and RS-61443. American Society of Transplant Physicians Abstract Book 1993; 12:238. (Presented).

87. Weir MR, Behrens MT. Increased sodium intake in hypertensives results in hyperfiltration fraction and increased microalbuminuria. J Am Soc Neph 1993; 4:590.

88. Weir MR, Houston MC, Grey JM. Effects of NSAIDs on blood pressure controlled by verapamil. J Am Soc Neph 1993; 4:542 (presented).

89. Nicholson PG, Raval DT, Behrens MT, Weir MR. A prospective crossover trial to compare the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemia in organ transplant recipients. J Am Soc Neph 1993; 4:952 (presented).

90. Weir MR, Hall PS, Behrens MT. Greater Antihypertensive response to the calcium antagonist isradipine in salt-sensitive vs. salt-resistant hypertensives. Am J Hypertens 1994; 7:8A.

91. Houston MC, Weir MR, Gray JM. Effects of NSAIDS on blood pressure controlled by verapamil. Am J Hypertens 1994; 7:105A.

92. Weir MR, Behrens MT. Sodium sensitivity, independent of race, predicts higher filtration fraction and microalbuminuria in hypertensives on higher sodium intake. Am J Hypertens 1994; 7:131A.

93. Weir MR. A pilot study to assess the influence of isradipine therapy on proteinuria in hypertensive patients with Type II diabetes. Am J Hypertens 1994; 7:131A.

94. Klassen DK, Weir MR, Nicholson RD, Schweitzer E, Bartlett ST. Isolated pancreas graft rejection in combined kidney pancreas transplantation; clinical results of percutaneous pancreas biopsy in 40 consecutive cases. Am Soc Transplant Physicians Abstract Book 1994; 13:60 (Presented).

95. Oldach D, Constantine N, Zhang Y, Abdel-Hamid M, Zhang X, Weir MR, Bartlett ST, Styuver L. Renal transplant donor and recipient HCV type characterization: Evidence for establishment of donor virus type viremia (superinfection) in recipients with prior HCV infection. 2nd International Meeting on Hepatitis C and Related Viruses (In Press).

96. Prisant LM, Weir MR, Papademetriou V, Adegbile A, Alemayehu D, Lefkowitz MP, Carr AA, Weber MA. Novel first line therapy for hypertension: Low dose combination drug therapy. Am Coll Clinical Pharmacol (In Press).

97. Oldach D, Constantine N, Zhang X, Abdel-Hamid M, Weir MR, Bartlett ST, Stuyver L. Hepatitis C virus transmission by renal transplant from a viremic donor into a receipient with prior infection (super-infection). J Am Soc Nephrol 1994;5:1028. (Presented).

98. Koya I, Doyle B, Dengel D, Weir MR. Influence of donor kidney race on post-transplantation blood pressure and renal function. J Am Soc Nephrol 1994; 5:115. (Presented).

99. Klassen DK, Weir MR, Johnson L, Schweitzer EJ, Bartlett ST. Isolated pancreas graft rejection in combined kidney pancreas transplantation: Clinical results of percutaneous pancreas biopsy. J Am Soc Nephrol 1994; 5:118. (Presented)

100. Weir MR, Malinow L, Klassen DK, Schweitzer EJ, Bartlett ST. A comparison of the incidence of delayed renal allograft function with OKT3, intra-operatively or post-operatively, vs polyclonal antilymphocyte globulin. J Am Soc Nephrol 1994; 5:1043 (presented).

101. Weir MR, Robinson S, Fisher ML, Krichten C, Gottlieb SS. 24 hour blood pressure monitoring to assess the role of hypotension in the renal deterioration associated with ACE inhibition in CHF. J Am Soc Nephrol 1994; 5:615.

102. Walker J, Weir MR, Klassen DK, Dunston R, Schweitzer EJ, Bartlett ST. Late pancreatic rejection: Inadequacy of current laboratory screening and importance of cyclosporine (CSA) levels. J Am Soc Nephrol 1994; 5:1043.


  1. Klassen DK, Papadimitriou JC, Drachenberg CB, Mayuga RS, Walker JA, Hooper FJ, Hoehn-Saric EW,

Schweitzer EJ,Bartlett ST, Weir MR. A proposed histologic grading system for acute pancreas allograft rejection: A

predictor of graft survival. Am Soc Transplant Physicians Abstract Book 1995; 14:111 (presented).



  1. Oldach D, Constatine N, Schweitzer EJ, Weir MR, Bartlett ST, Abdel-Hamid M, Zhang X, Keay S, Stuyver L. Clinical

  2. Virologic outcomes in Hepatitis C Virus (HCV) infected renal transplant recipients. Am Soc Transplant Physicians Abstract Book 1995;14:98 (presented).

  3. Walker JA, Klassen DK, Hoehn-Saric EW, Hooper FJ, Schweitzer EJ, Johnson LB, Bartlett ST, Weir MR. Acute pancreas

  4. allograft rejection after the first year: Predisposing factors. Am Soc Transplant Physicians Abstract Book 1995;14:155. (presented).

  5. Hoehn-Saric EW, Wiland A, Weir MR, Klassen DK, Schweitzer EJ, Johnson LB, Bartlett ST. Initial experience with tacrolimus as rescue therapy for refractory pancreatic allograft rejection. Am Soc Transplant Physicians Abstract Book 1995; 14:155. (presented)

  6. Wiland A, Schweitzer EJ, Johnson LB, Anderson L, Klassen DK, Weir MR, Bartlett ST. Omission of anti-thymocyte globulin (ATG) induction in haplo-and non-identical living donor transplants prolongs initial hospitalization. Am Soc Transplant Physicians Abstract Book 1995; 14:178. (presented)

  7. Weir MR, Saunders E and the Trandolapril Multicenter Study Group. Differing mechanisms of action of angiotensin converting enzyme inhibition in black and white hypertensives. Am J Hypertens 1995; 8:138A (presented).

  8. Moy E, Bartman B, Weir MR. Effects of income, insurance and source of care on hypertensive care. Am J of Hypertension 1995; 8:79. (presented)

  9. Weir MR, Prisant LM, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, Lefkowitz MP. Correlation of prior antihypertensive therapy, current therapy (amlodipine, bisoprolol/HCTZ, enalapril), adverse events and blood pressure reduction with changes in quality of life. Am J Hypertens 1995; 8:132A. (presented)

  10. Weir MR, Dengel DR, Behrens MT, Goldberg AP. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Am J Hypertens 1995; 8:156A. (presented)

  11. Dailey G, Boden G, Creech R, D'Elia J, Johnson D, Kennedy F, Weir MR. Weekly pulsatile IV insulin treatments appear to slow progression of diabetic nephropathy. American Diabetes Association Annual Meeting 1995. Diabetes 1995; 44:24A.

  12. Stewart D, DeForge B, Moy E, Tijani T, Weir MR. Similarities and differences between working poor and unemployed poor hypertensives. Abstract Book of the International Society of Hypertension in Blacks, 1995. (presented)

  13. Shearer GM, Grady RW, Schulick RD, Muluk S, Miller MW, Weir MR, Ohler L, Miller JA, Kimmel PL, Clerici M. Direct versus Indirect Antigen Presentation. Abstract book of the XIIIth International Congress of Nephrology. (presented)

  14. Weir MR, Dengel DR, Mayuga RS, Goldberg AP. Insulin resistance, elevated glomerular filtration fraction and renal injury. Council for High Blood Pressure Research 49 th Annual Fall Conference and Scientific Sessions. Hypertension 1995; 25:16, P2. (presented)

  15. Wiland A, Schweitzer EJ, Anderson LM, Johnson LB, Kuo P, Weir MR, Klassen DK, Hoehn-Saric EW, Bartlett ST. The benefits of CD3 monitoring during ATGAM administration. Am Soc Transplant Physicians Abstract Book May 1996; P-74:191(A).

  16. Keay S, Oldach D, Wiland A, Abruzzo L, Kumar D, Weir MR, Klassen DK, Hoehn-Saric EW, Schweitzer EJ, Johnson LB, Kuo P, Bartlett ST. Early onset post-transplant lymphoproliferative disorder associated with OKT3 in EBV-seropositive pancreas transplant recipients. Am Soc Transplant Physicians Abstract Book May 1996; 160:124(A).

118. Hadley GA, Bartlett ST, Gomolka DM, Rostapshova EA, Weir MR. A major subpopulation of human alloreactive CD8 cells express E integrin. Am Soc Transplant Physicians Abstract Book May 1996; 283:155(A).

119. White M, Hanes D, Wiland A, Klassen DK, Hoehn-Saric EW, Schweitzer EJ, Kuo P, Johnson LB, Bartlett ST, Weir MR. Long-term treatment of hyperlipidemia in transplant recipients with pravastatin and gemfibrozil. Am Soc Transplant Physicians Abstract Book May 1996; P-270:240(A).

120. Drachenberg D, Klassen DK, Papdimitriou J, Weir M, Hoehn-Saric E, Light P, Ramos E, Kuo P, Schweitzer E, Johnson L, Hanes D, Bartlett S. Histologic findings in islets of pancreatic allografts: Lack of evidence for recurrent cell mediated diabetes mellitus (DM). Am Soc Transplant Physicians Abstract Book May 1996; 154:123(A).

121. Oldach DW, Pfundstein J, Morris JG, Keay S, Schwalbe RS, Qaiyumi SQ, Weir M, Klassen D, Johnson L, Schweitzer E, Bartlett ST. A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in kidney and pancreas transplant recipients. Am Soc Transplant Physicians Abstract Book 1996 (In Press).

122. Johnson L, Weir MR, Kuo P, Schweitzer E, Ridge L, Hoehn-Saric E, Klassen D, Bartlett S. Stable renal function in recipients of double renal allografts from marginal donors. Am Soc Transplant Physicians Abstract Book May 1996; 307:161(A).

123. Johar B, Brechemin L, Klassen DK, Hoehn-Saric EW, Schweitzer EJ, Anderson L, Allen E, Bartlett S, Weir MR. Tertiary hyperparathyroidism in renal transplant (Tx) patients. Am Soc Transplant Physicians Abstract Book May 1996; P-271:241(A).

124. Hoehn-Saric EW, Wiland A, Klassen DK, Anderson L, Schweitzer EJ, Johnson L, Kuo P, Bartlett S, Weir MR. The efficacy of short term FK506 therapy in treating refractory pancreas rejection. Am Soc Transplant Physicians Abstract Book May 1996;250:147(A).

125. Klassen DK, Weir MR, Hoehn-Saric E, Anderson L, Kuo P, Johnson L, Schweitzer E, Bartlett ST. Cyclosporine vs. Tacrolimus as maintenance immunosuppression in simultaneous kidney pancreas (SPK) transplantation: preliminary results. Am Soc Transplant Physicians Abstract Book 1996 (In Press).

126. Klassen DK, Hoehn-Saric EW, Weir MR, Light P, Schweitzer E, Johnson L, Kuo P, Bartlett ST, Papadimitriou JC, Drachenberg C. Occult kidney rejection in simultaneous kidney pancreas transplantation (SPK). Am Soc Transplant Physicians Abstract Book May 1996; 155:123(A).

127. Schweitzer E, Anderson L, Johnson L, Kuo P, Weir MR, Klassen DK, Hoehn-Saric EW, Bartlett ST. Safe pancreas transplantation in diabetics with ischemic heart disease. Am Soc Transplant Physicians Abstract Book 1996.

128. Weir MR, Saunders E. Racial similarity in response to the angiotensin converting enzyme inhibitor trandolapril. Am J Hypertens 1996; 9(4):174A.

129. Weir MR. Efficacy and safety of losartan versus calcium channel blockers in hypertension.

130. Weir MR. Antagonism of angiotensin II: new understandings about the interrelationship with dietary salt and blood pressure reduction.

131. Bakris GL, Weir MR, DeQuattro V, Rosendorff C, McMahon G. Renal hemodynamic and antiproteinuric response to an ACE inhibitor, Trandolopril (T) or calcium antagonist, verapamil (V) alone or in fixed dose combination in patents with diabetic nephropathy: A randomized multicenter study. J Amer Soc Nephr A1470:1546. 1996.

132. Yoon SW, Evans D, Jaekels J, Schweitzer EJ, Johnson LB, Kuo P, Weir MR, Klassen D, Hoehn-Saric E, Bartlett ST. Increased living donor volunteer rates with a formal recipient family education program. Am Soc Transplant Physicians Abstract Book May 1996;P-297:247(A).

133. Weir MR, Weder A, for the MIST Study Group. Influence of race and dietary salt on blood pressure (BP) responses in salt sensitive hypertensives. AJH 1997; 10:19A.

134. Weir MR, Reisin E, Falkner B, Hutchinson HG, Anzalone D, Tuck M for the TROPHY Study Group. Effect of lisinopril (L), hydrochlorothiazide (H) and dipper/non-dipper status on 24-hour ambulatory blood pressure (ABP) in obese hypertensives. AJH 1997; 10:77A.

135. Weir MR, Cargo PH, Colasante D, McDevitt JT, Oparil S. Differential effects of calcium channel blockers on heart rate in women. AJH 1997; 10:106A.

136. Weir MR. Therapeutic approaches to patients with special indications. AJH 1997; 10:228A.

137. Weir MR. Hypertension progressing to renal failure: is there a way out? AJH 1997; 10:233A.

138. Weir MR. The rationale for combination therapies vs. single entities in hypertension. AJH 1997; 10:241A.

139. Weir MR. Efficacy and safety of losartan versus calcium channel blockers in hypertension. AJH 1997; 10:243A.

140. Fink JC, Roghmann M, Gabregiorgish K, Antonopoulos G, Maker T, Weir MR, Polish LB, Morris JG, Light PD. Vancomycin resistant enterococcus in patients on hemodialysis: risk factors and outcomes. J Amer Soc Nephr 1997; A1081:235A.

141. Fink JC, Stehman-Breen CO, Kufera JL, Weir MR, Hooper FJ. Patients from the same dialysis unit are not independent observations: estimation of within center correlations in the USRDS. J Amer Soc Nephr 1997; A1301:283A.

142. Song H, Papadimitriou J, Drachenberg C, Weir MR, Wei C. Presentation and localization of renal endothelin-1 (ET), ET receptors and ET converting enzyme expression in human renal biopsy with rejection after kidney transplantation. J Amer Soc Nephr 1997; A1559:339A.

143. Song H, Papadimitriou J, Drachenberg C, Weir MR, Wei C. Increase the expression of natriuretic peptides and cGMP in rejected human renal graft. J Amer Soc Nephr 1997; A1886:407A.

144.Wei C, Song H, Papadimitriou J, Drachenberg C, Weir MR. Protein expression of apoptosis related-gene in human renal graft rejection. J Amer Soc Nephr 1997; A1994:430A.

145.Wei C, Song H, Papadimitriou J, Drachenberg C, Weir MR. Increase transforming growth factor- and its receptors in human renal tissue with rejection. J Amer Soc Nephr 1997;;A3354:722A.

146. Wei C, Song H, Papadimitriou J, Drachenberg C, Weir MR. Nitric oxide synthase in human renal graft rejection after kidney transplantation. J Amer Soc Nephr 1997; A3355:722A.

147. Drachenberg CB, Fink JC, Klassen DK, Hoehn-Saric EW, Anderson L, Brechemin L, Bartlett ST, Weir MR, Papadimitriou JC. Transplant glomerulopathy: relationship with long term arterial hypertension. Am Soc Transplant Physicians Abstract Book 1997;104:110A.

148. Maddox L, McCarter R, Kumar D, Weir MR, Bartlett ST, Keay S, Oldach D. Transplant esophagitis: microbiological, pathological, and clinical correlates in a series of 97 episodes in kidney and pancreas Tx precipients. Am Soc Transplant Physicians Abstract Book 1997;109:112A.

149. Nogueira J, Drachenberg CB, Papadimitriou JC, Fink JC, Hoehn-Saric E, Klassen DK, Cangro CB, Bartlett ST, Weir MR. Prognostic significance of eosinophils on renal allograft biopsy with acute rejection. Am Soc Transplant Physicians Abstract Book 1997;161:125A.

150. Weir MR, Anderson L, Fink JC, Schweitzer E, Hoehn-Saric E, Klassen D, Cangro CM, Kuo P, Johnson L, Lim J, Bartlett ST. A new approach to the treatment of chronic allograft nephropathy. Am Soc Transplant Physicians Abstract Book 1997; 398:184A.

151. Oldach D, Constantine N, Schweitzer E, Madayag R, Bartlett S, Weir MR, Yang Q, Rowe J, Foung S, Hadlock K. Prevalence and significance of hepatitis viruses C & G in allograft recipients. Am Soc Transplant Physicians Abstract Book 1997; 562:225A.

152. Madayag R, Johnson L, Bartlett ST, Schweitzer E, Constantine N, McCarter R, Kuo P, Weir MR,

Oldach D. Use of allografts from donors positive for hepatitis B core antibody confer minimal risk for subsequent

development of hepatitis B virus (HBV) infection. Am Soc Transplant Physicians Abstract Book 1997; 565:226A


  1. Weir MR, Fink JC, Hanes DS, et al. Chronic allograft nephropathy effect of cyclosporine reduction and addition of mycophenolate on progression of renal disease. Transplantation 1999;67:S82.

  2. Klassen DK, Fink J, Blahut S, Weir MR. Delayed function after pancreas transplantation: effects on allograft rejection and survival. Transplantation 1999; 67:S171.

  3. Drachenberg CB, Klassen DK, Wiland A, Weir MR. Islet cell damage associated with tacrolimus and cyclosporine morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999; 67:S209.

  4. Drachenberg CB, Beskow CO, Papadimitriou JC, Cangro CB, Rocca M, Klassen DK, Weir MR. Human polyoma virus infected cells (POVIC): incidence in renal biopsies (BX), urine cytology and correlation with clinical presentation. Transplantation 1999;67:S217.

  5. Hanes DS, Wali R, Fink JC, Klassen DK Cangro CB, Bartlett ST, Weir MR. Comparison of the incidence of acute rejection in simultaneous pancreas-kidney transplant recipients receiving either tacrolimus (FK506) or cyclosporine microemulsion (Neoral) in combination with mycophenolate mofetil (MMF) and corticosteroids. Transplantation 1999; 67:S224.

  6. Weir MR, Traver M, Blahut SA, Klassen DK, et al. The long-term impact calcineurin inhibitor reduction or discontinuation in patients with declining kidney function due to chronic allograft nephropathy. Transplantation 2000; 69:S163.

  7. Weir MR, Ward M, Blahut S, Klassen DK, et al. The influence of blood pressure, serum cholesterol and glucose on the rate of loss of renal function in renal transplant recipients with chronic allograft nephropathy after calcineurin inhibitor dose reduction. J Am Soc Nephrol 2000; 11: 712A.

  8. Weir MR, Ward M, Klassen DK, et al. The role of blood pressure and metabolic factors in predicting graft loss in patients with chronic allograft nephropathy (CAN) after calcineurin inhibitor reduction or cessation. J Am Soc Nephrol 2000; 11: 712A

  9. Salmanullah M, Blahut S, Sawyer R, Fink JC, Weir MR, Henrich, WL. Hise M. Patterns of Creatinine Elevation in a VA Hospital. J Am Soc Nephrol 2000; 11:164A

  10. Salmanullah M, Sawyer R, Henrich WL, Weir MR, Fink JC, Hise MK. The natural history of an elevated creatinine in a VA population. J Am Soc Nephrol 2000; 11:164A

  11. Salmanullah M, Sawyer R, Henrich WL, Weir MR, Fink JC, Hise MK. Control of clinical parameters (CP) in a subspeciality setting. J Am Soc Nephrol 2000; 11:164A.

Stopped listing in 2000 due to space constraints.



1   2   3   4   5   6   7


The database is protected by copyright ©dentisty.org 2016
send message

    Main page